135 related articles for article (PubMed ID: 2804589)
1. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery.
Taberner DA; Poller L; Thomson JM; Lemon G; Weighill FJ
Br J Surg; 1989 Sep; 76(9):933-5. PubMed ID: 2804589
[TBL] [Abstract][Full Text] [Related]
2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
3. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.
Leyvraz PF; Richard J; Bachmann F; Van Melle G; Treyvaud JM; Livio JJ; Candardjis G
N Engl J Med; 1983 Oct; 309(16):954-8. PubMed ID: 6621623
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery.
Dechavanne M; Ville D; Berruyer M; Trepo F; Dalery F; Clermont N; Lerat JL; Moyen B; Fischer LP; Kher A
Haemostasis; 1989; 19(1):5-12. PubMed ID: 2537787
[TBL] [Abstract][Full Text] [Related]
5. Adjusted subcutaneous heparin versus heparin plus dihydroergotamine in prevention of deep vein thrombosis after total hip arthroplasty.
Leyvraz P; Bachmann F; Vuilleumier B; Berthet S; Bohnet J; Haller E
J Arthroplasty; 1988; 3(1):81-6. PubMed ID: 3361324
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery.
Poller L; Taberner DA; Sandilands DG; Galasko CS
Thromb Haemost; 1982 Feb; 47(1):50-3. PubMed ID: 7071805
[TBL] [Abstract][Full Text] [Related]
7. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW
Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Hull RD; Gent M
N Engl J Med; 1986 Oct; 315(15):925-9. PubMed ID: 3531851
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis.
Gent M; Roberts RS
Chest; 1986 May; 89(5 Suppl):396S-400S. PubMed ID: 3516587
[No Abstract] [Full Text] [Related]
10. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery.
Lahnborg G
Acta Chir Scand; 1980; 146(5):319-22. PubMed ID: 7468062
[TBL] [Abstract][Full Text] [Related]
11. Heparin prophylaxis of deep vein thrombosis in patients with a fractured neck of the femur.
Xabregas A; Gray L; Ham JM
Med J Aust; 1978 Jun; 1(11):620-2. PubMed ID: 355810
[TBL] [Abstract][Full Text] [Related]
12. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial.
Huo MH; Salvati EA; Sharrock NE; Brien WW; Sculco TP; Pellicci PM; Mineo R; Go G
Clin Orthop Relat Res; 1992 Jan; (274):35-46. PubMed ID: 1729021
[TBL] [Abstract][Full Text] [Related]
14. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.
Eriksson BI; Ekman S; Kalebo P; Zachrisson B; Bach D; Close P
Lancet; 1996 Mar; 347(9002):635-9. PubMed ID: 8596376
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement.
Francis CW; Pellegrini VD; Harris CM; Marder VJ
Am J Med; 1989 Sep; 87(3B):61S-66S. PubMed ID: 2478015
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.
Sagar S; Nairn D; Stamatakis JD; Maffei FH; Higgins AF; Thomas DP; Kakkar VV
Lancet; 1976 May; 1(7970):1151-4. PubMed ID: 58199
[TBL] [Abstract][Full Text] [Related]
18. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
[TBL] [Abstract][Full Text] [Related]
19. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
[TBL] [Abstract][Full Text] [Related]
20. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures.
Moskovitz PA; Ellenberg SS; Feffer HL; Kenmore PI; Neviaser RJ; Rubin BE; Varma VM
J Bone Joint Surg Am; 1978 Dec; 60(8):1065-70. PubMed ID: 363722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
